Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Operating Expenses: 2011-2024

Historic Operating Expenses for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $237.4 million.

  • Mimedx Group's Operating Expenses rose 28.83% to $72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $268.1 million, marking a year-over-year increase of 16.75%. This contributed to the annual value of $237.4 million for FY2024, which is 6.09% up from last year.
  • Mimedx Group's Operating Expenses amounted to $237.4 million in FY2024, which was up 6.09% from $223.8 million recorded in FY2023.
  • Mimedx Group's 5-year Operating Expenses high stood at $237.4 million for FY2024, and its period low was $192.7 million during FY2020.
  • Over the past 3 years, Mimedx Group's median Operating Expenses value was $223.8 million (recorded in 2023), while the average stood at $227.5 million.
  • In the last 5 years, Mimedx Group's Operating Expenses dropped by 7.93% in 2020 and then climbed by 8.10% in 2022.
  • Mimedx Group's Operating Expenses (Yearly) stood at $192.7 million in 2020, then rose by 6.25% to $204.8 million in 2021, then increased by 8.10% to $221.4 million in 2022, then increased by 1.09% to $223.8 million in 2023, then increased by 6.09% to $237.4 million in 2024.